120
edits
Changes
Jump to navigation
Jump to search
mLine 314:
Line 314: − + − + − § ''[[PTEN]]'' (Cowden Syndrome)+ − + − § ''[[FLCN]]'' (Birt-Hogg-Dube syndrome)+ − + − § ''[[TSC1]]'' and ''[[TSC2]]'' (tuberous sclerosis)+ − + − § ''[[SDHB]] (most common), [[SDHC]] (less common), [[SDHA]] (rare), [[SDHD]] (rare)'' (succinate dehydrogenase deficient RCC)+ − + −
Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations (view source)
Revision as of 00:01, 15 January 2021
, 00:01, 15 January 2021added bullets
|-
|-
|Germline susceptibility
|Germline susceptibility
|§ mainly ''[[VHL]]'' (von Hippel-Lindau Syndrome)
|
* mainly ''[[VHL]]'' (von Hippel-Lindau Syndrome)
* ''[[PTEN]]'' (Cowden Syndrome)
* ''[[FLCN]]'' (Birt-Hogg-Dube syndrome)
* ''[[TSC1]]'' and ''[[TSC2]]'' (tuberous sclerosis)
* ''[[SDHB]] (most common), [[SDHC]] (less common), [[SDHA]] (rare), [[SDHD]] (rare)'' (succinate dehydrogenase deficient RCC)
|
* ''[[MET]]'' (Hereditary papillary RCC)
|
|§ ''[[MET]]'' (Hereditary papillary RCC)
* ''[[FH]]'' (Hereditary leiomyomatosis and RCC)
|§ ''[[FH]]'' (Hereditary leiomyomatosis and RCC)
|
|
| colspan="2" |''[[FCLN]]'' (Birt-Hogg-Dube syndrome)
| colspan="2" |''[[FCLN]]'' (Birt-Hogg-Dube syndrome)